The Wistar Institute's Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center's Molecular and ...

The POLAR genomic signature can help predict the patients with early breast cancer who may benefit from adjuvant radiotherapy ...

PHILADELPHIA, PA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- PHILADELPHIA — (November 21, 2024) — The Wistar Institute’s Nan Zhang, Ph ...

Vaidehi Mahajan said To improve cancer care, we need to focus on giving healthcare providers immediate access to the ...

AstraZeneca, in partnership with the Moi Teaching & Referral Hospital (MTRH), has launched an advanced molecular testing ...

PET imaging using a radiolabeled antibody picked up clear cell renal cell carcinoma and could help avert unnecessary biopsies ...

Researchers at Saint Louis University's School of Medicine say T-cell dysfunction is leading to an increased risk of cancer ...

"Metastatic breast cancer is where breast cancer moves from the origin in the breast through the blood, and through the lymph ...

A new study finds that, in healthy women, some breast cells that otherwise appear normal may contain chromosome abnormalities typically associated with invasive breast cancer. The findings question ...

The findings question conventional thinking on the genetic origins of breast cancer, which could influence early cancer ...

Gastrointestinal (GI) cancers are among the most common cancer types affecting millions worldwide with a poor survival rate ...

James Desmet explores Targeted Protein Degradation, a potential drug discovery strategy capable of treating previously undruggable diseases.